These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35355673)

  • 1. Risk factors for lymph node metastasis and indication of local resection in duodenal neuroendocrine tumors.
    Nakao E; Namikawa K; Hirasawa T; Nakano K; Tokai Y; Yoshimizu S; Horiuchi Y; Ishiyama A; Yoshio T; Nunobe S; Fujisaki J
    JGH Open; 2022 Mar; 6(3):189-195. PubMed ID: 35355673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.
    Zhang XF; Wu XN; Tsilimigras DI; Poultsides G; Rocha F; Abbott DE; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(8):1302-1310. PubMed ID: 31680243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.
    Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J
    J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic Management of Diminutive Duodenal Neuroendocrine Tumors.
    Klemm N; Lu-Cleary D; Chahal D; Trasolini R; Lam E; Donnellan F
    J Gastrointest Cancer; 2021 Jun; 52(2):448-453. PubMed ID: 33471257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection.
    Tran CG; Sherman SK; Suraju MO; Nayyar A; Gerke H; Abiad RGE; Chandrasekharan C; Ear PH; O'Dorisio TM; Dillon JS; Bellizzi AM; Howe JR
    Ann Surg Oncol; 2022 Jan; 29(1):75-84. PubMed ID: 34515889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.
    Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB
    World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic mucosal resection using a ligation device for duodenal neuroendocrine tumors: a simple method.
    Inokuchi Y; Hayashi K; Kaneta Y; Okubo Y; Watanabe M; Furuta M; Machida N; Maeda S
    Ther Adv Gastrointest Endosc; 2022; 15():26317745221103735. PubMed ID: 35706683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic resection using an over-the-scope clip for duodenal neuroendocrine tumors.
    Tashima T; Ryozawa S; Tanisaka Y; Fujita A; Miyaguchi K; Ogawa T; Mizuide M; Mashimo Y; Kawasaki T; Yasuda M
    Endosc Int Open; 2021 May; 9(5):E659-E666. PubMed ID: 33937505
    [No Abstract]   [Full Text] [Related]  

  • 9. Laparoscopic and endoscopic co-operative surgery for non-ampullary duodenal tumors.
    Ichikawa D; Komatsu S; Dohi O; Naito Y; Kosuga T; Kamada K; Okamoto K; Itoh Y; Otsuji E
    World J Gastroenterol; 2016 Dec; 22(47):10424-10431. PubMed ID: 28058023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer.
    Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB
    Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors of Lymph Node Metastasis in Patients with Early Pure and Mixed Signet Ring Cell Gastric Carcinomas.
    Hu Q; Dekusaah R; Cao S; Pang T; Wang Y; Zhang B; Lv Y; Zhang X; Ling T; Zhuge Y; Wang L; Zou X; Zhang W; Huang Q; Xu G
    J Cancer; 2019; 10(5):1124-1131. PubMed ID: 30854120
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: a systematic review and meta-analysis.
    Hatta W; Gotoda T; Kanno T; Yuan Y; Koike T; Moayyedi P; Masamune A
    J Gastroenterol; 2020 Aug; 55(8):742-753. PubMed ID: 32277297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features and risk factors for lymph node metastasis in early-stage non-ampullary duodenal adenocarcinoma.
    Yoshimizu S; Kawachi H; Yamamoto Y; Nakano K; Horiuchi Y; Ishiyama A; Tsuchida T; Yoshio T; Hirasawa T; Ito H; Fujisaki J
    J Gastroenterol; 2020 Aug; 55(8):754-762. PubMed ID: 32533301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive lymph node dissection may be necessary in minute submucosal cancer of the stomach after endoscopic resection.
    Kim JH; Lee YC; Kim H; Yoon SO; Kim H; Youn YH; Park H; Lee SI; Choi SH; Noh SH
    Ann Surg Oncol; 2012 Mar; 19(3):779-85. PubMed ID: 21964889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data.
    Lin JX; Wang ZK; Wang W; Desiderio J; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Parisi A; Zhou ZW; Huang CM
    BMC Cancer; 2019 Nov; 19(1):1048. PubMed ID: 31694573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of lymph node metastasis after endoscopic treatment for rectal NETs 10 mm or less.
    Inada Y; Yoshida N; Fukumoto K; Hirose R; Inoue K; Dohi O; Murakami T; Ogiso K; Tomie A; Kugai M; Yoriki H; Inagaki Y; Hasegawa D; Okuda K; Okuda T; Morinaga Y; Kishimoto M; Itoh Y
    Int J Colorectal Dis; 2021 Mar; 36(3):559-567. PubMed ID: 33388960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.
    Zhou YJ; Wang QW; Zhang QW; Chen JN; Wang XY; Gao YJ; Li XB
    Front Endocrinol (Lausanne); 2021; 12():658392. PubMed ID: 34122337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and long-term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort.
    Namikawa K; Kamada T; Fujisaki J; Sato Y; Murao T; Chiba T; Kaizaki Y; Ishido K; Ihara Y; Kurahara K; Suga T; Suzuki H; Ito M; Hirakawa K; Maruyama Y; Gotoda T; Hosokawa O; Koike T; Mabe K; Yao T; Inui K; Iishi H; Ogata H; Furuta T; Haruma K;
    Dig Endosc; 2023 Sep; 35(6):757-766. PubMed ID: 36721901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer.
    Pyo JH; Lee H; Min YW; Min BH; Lee JH; Kim KM; Yoo H; Ahn S; Kim JJ
    Gastric Cancer; 2018 Jul; 21(4):672-679. PubMed ID: 29243195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and prognostic factors of duodenal neuroendocrine tumours: A comparative study of ampullary and nonampullary regions.
    Fang S; Shi YP; Wang L; Han S; Shi YQ
    World J Gastrointest Oncol; 2024 Mar; 16(3):907-918. PubMed ID: 38577444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.